openPR Logo
Press release

Asthma Drugs Market worth $33.59 billion by 2030, growing at a CAGR of 8.59% - Exclusive Report by 360iResearch

11-22-2023 01:50 PM CET | Health & Medicine

Press release from: 360iResearch

Asthma Drugs Market | 360iResearch

Asthma Drugs Market | 360iResearch

The "Asthma Drugs Market by Product (Long-Term Control Medications, Medications for Allergy-Induced Asthma, Quick-Relief Medications (Rescue Medications)), Application (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Global Forecast 2023-2030" report has been added to 360iResearch.com's offering.

The Global Asthma Drugs Market to grow from USD 17.37 billion in 2022 to USD 33.59 billion by 2030, at a CAGR of 8.59%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/asthma-drugs?utm_source=openpr&utm_medium=referral&utm_campaign=sample

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Asthma Drugs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Asthma Drugs Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Asthma Drugs Market, highlighting leading vendors and their innovative profiles. These include ALK-Abelló A/S, Amphastar Pharmaceuticals, Inc., AstraZeneca PLC, Boehringer Ingelheim International GmbH, CHIESI Farmaceutici S.p.A., Cipla Limited, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Hetero Labs Limited, Lallemand Inc., Merck KGaA, Mundipharma International Limited, NIOX Group PLC, Novartis AG, OPKO Health, Inc., Sanner GmbH, Sanofi S.A., Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Verona Pharma PLC, and Viatris, Inc..

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/asthma-drugs?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

Market Segmentation & Coverage:

This research report categorizes the Asthma Drugs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Long-Term Control Medications, Medications for Allergy-Induced Asthma, and Quick-Relief Medications (Rescue Medications). The Quick-Relief Medications (Rescue Medications) is projected to witness significant market share during forecast period.

Based on Application, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy. The Retail Pharmacy is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Asthma Drugs Market, by Product
7. Asthma Drugs Market, by Application
8. Americas Asthma Drugs Market
9. Asia-Pacific Asthma Drugs Market
10. Europe, Middle East & Africa Asthma Drugs Market
11. Competitive Landscape
12. Competitive Portfolio
13. Appendix

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Asthma Drugs Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Asthma Drugs Market?
3. What is the competitive strategic window for opportunities in the Asthma Drugs Market?
4. What are the technology trends and regulatory frameworks in the Asthma Drugs Market?
5. What is the market share of the leading vendors in the Asthma Drugs Market?
6. What modes and strategic moves are considered suitable for entering the Asthma Drugs Market?

Read More @ https://www.360iresearch.com/library/intelligence/asthma-drugs?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asthma Drugs Market worth $33.59 billion by 2030, growing at a CAGR of 8.59% - Exclusive Report by 360iResearch here

News-ID: 3298102 • Views:

More Releases from 360iResearch

Voice Analytics Market worth $11.00 billion by 2030, growing at a CAGR of 23.21% - Exclusive Report by 360iResearch
Voice Analytics Market worth $11.00 billion by 2030, growing at a CAGR of 23.21% …
The "Voice Analytics Market by Components (Services, Solution), Organization (Large Enterprises, Small & Medium Enterprises), End-Use, Application, Deployment Mode - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/voice-analytics?utm_source=openpr&utm_medium=referral&utm_campaign=sample "Voice Analytics Market Surges as Strategic Innovation Meets Growing Demands for Data Privacy and Customer Experience" In the evolving landscape of customer relations, voice analytics has emerged as a pivotal technology, enabling businesses to decode intricate
Benzophenone Market worth $442.30 million by 2030, growing at a CAGR of 6.26% - Exclusive Report by 360iResearch
Benzophenone Market worth $442.30 million by 2030, growing at a CAGR of 6.26% - …
The "Benzophenone Market by Purity (95% Purity, 97% Purity, 99% Purity), Application (Adhesives & Sealants, Agrochemical, Home Care) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/benzophenone?utm_source=openpr&utm_medium=referral&utm_campaign=sample "Benzophenone Market Thrives on Diverse Applications Across Industries, Boosted by Innovations and Regulatory Support" Benzophenone, widely recognized for its UV blocking properties, is experiencing a surge in demand due to heightened consumer awareness of skincare and the
Ferroalloys Market worth $73.95 billion by 2030, growing at a CAGR of 7.15% - Exclusive Report by 360iResearch
Ferroalloys Market worth $73.95 billion by 2030, growing at a CAGR of 7.15% - Ex …
The "Ferroalloys Market by Product (Ferro Silico Manganese, Ferrochrome, Ferromanganese), Application (Alloy Steel, Carbon & Low Alloy steel, Cast Iron) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/ferroalloys?utm_source=openpr&utm_medium=referral&utm_campaign=sample "Enhancing Global Infrastructure and Technology through Strategic Expansion of the Ferroalloys Market" As developing economies in Asia and Africa continue their rapid growth, there is an escalating demand for steel and metal alloys, crucial for
Space Sensors & Actuators Market worth $16.34 billion by 2030, growing at a CAGR of 18.84% - Exclusive Report by 360iResearch
Space Sensors & Actuators Market worth $16.34 billion by 2030, growing at a CAGR …
The "Space Sensors & Actuators Market by Product Type (Actuators, Sensors), Platform (Capsules or Cargos, Interplanetary Spacecraft & Probes, Launch Vehicle), Application, End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/space-sensors-actuators?utm_source=openpr&utm_medium=referral&utm_campaign=sample "Key Drivers Fueling the Growth of the Global Space Sensor and Actuator Market" The increasing deployment of satellites is boosting the demand for space sensors and actuators, essential for operations ranging from

All 5 Releases


More Releases for Asthma

Asthma Treatment Market: Increase in Prevalence of Asthma and Rise in Awareness …
Transparency Market Research (TMR) has published a new report on the asthma treatment market for the forecast period of 2019–2027. According to the report, the global asthma treatment market was valued at ~US$ 25 Bn in 2018, and is projected to expand at a CAGR of ~2% from 2019 to 2027. Read Report Overview - https://www.transparencymarketresearch.com/asthma-treatment-market.html Overview Asthma treatment involves two main types of medications: long-term asthma control medications and quick-relief (rescue) medications. Asthma
Anti-Asthma Drugs Market Factors Affecting Market Growth 2018 | Key Type of Asth …
To Track and Analyze Competitive Developments such as Joint Ventures, Strategic Alliances, Mergers and Acquisitions, New Product Developments, and Research and Developments Globally. The all things added in “Global Anti Asthma Drugs Market Research Report – Forecast to 2022” – Avail Prime Report to MRFR Anti-Asthma Drugs Market - Overview With the air pollution rising around the world, the number of asthma patients is also increasing. Therefore the market for the drugs
Asthma-Pipeline Review H2 2017
ReportsWeb.com published “Asthma” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Asthma-Pipeline Review, H2 2017, provides an overview of the Asthma (Respiratory) pipeline landscape. Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow
Landmark Asthma Study Demonstrates Device Choice Determines Asthma Control
Monaghan Medical Corporation understands that for those with asthma, particularly children, choosing the device that best delivers their medication is an important consideration. Plattsburgh, NY, USA -- Monaghan Medical Corporation understands that for those with asthma, particularly children, choosing the device that best delivers their medication is an important consideration. Research has shown that even when using the same metered-dose inhaler (MDI), not all valved holding chambers perform equally well.[1] A landmark
Asthma-Pipeline Review H2 2017
ReportsWeb.com published “Asthma” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Asthma-Pipeline Review, H2 2017, provides an overview of the Asthma (Respiratory) pipeline landscape. Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow
Asthma Therapeutics Market to 2020 - Personalized Treatment for Severe Asthma to …
Recent Research, a leading business intelligence provider, has released its latest research report: “Asthma Therapeutics Market to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations.” The asthma therapeutics market is forecast to grow marginally over the forecast period across the top eight developed nations, from $18.4 billion in 2013 to a projected value of $21.7 billion by 2020 at a Compound Annual Growth Rate (CAGR)